Page 7 - Contracts And Orders News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Contracts and orders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Contracts And Orders Today - Breaking & Trending Today

ION awarded exclusive agreement for 3D multi-client programs offshore Kenya

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
ION awarded exclusive agreement for 3D multi-client programs offshore Kenya
ION Geophysical CorporationApril 8, 2021 GMT
HOUSTON, April 08, 2021 (GLOBE NEWSWIRE) ION Geophysical Corporation (NYSE: IO) today announced that the Company was awarded an exclusive agreement for 3D multi-client programs offshore Kenya. The agreement includes both 3D new acquisition offshore the Lamu Basin and reimaging vintage data offshore Kenya. Offshore Kenya is an attractive area with a proven petroleum system; however, it has remained underexplored, in part due to lack of available 3D data. The final shape and size of new 3D programs will be dictated by client input and underwriting. ....

United States , Rachel White , Joe Gagliardi , Mike Morrison , Geophysical Corporation , Kenya Ministry Of Energy , Lamu Basin , Offshore Kenya , Senior Vice President , Vice President , Chief Financial Officer , Corporate News , East Africa , Energy Industry , Oil And Gas Industry , Globe Newswire , Contracts And Orders , ஒன்றுபட்டது மாநிலங்களில் , ரேச்சல் வெள்ளை , ஓஹோ காகிளியர்டி , மைக் மோரிசன் , புவி இயற்பியல் நிறுவனம் , கேந்ய அமைச்சகம் ஆஃப் ஆற்றல் , லாமு பேசின் , மூத்தவர் துணை ப்ரெஸிடெஂட் , துணை ப்ரெஸிடெஂட் ,

Biofrontera reports results for the 2020 financial year

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Biofrontera reports results for the 2020 financial year
Biofrontera AGApril 12, 2021 GMT
Leverkusen, Germany, April 12, 2021 (GLOBE NEWSWIRE) Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its consolidated results for the fiscal year ended December 31, 2020. At the same time, the Company provided an overview of current operational and clinical developments.
Key financial figures FY2020
Revenue decreased by 3% to EUR 30.3 million compared to EUR 31.3 million in 2019;
Loss from operations amounted to EUR 7.6 million compared to a loss of EUR 23.4 million in 2019; ....

United States , United Kingdom , Baltic States , Biofrontera Pharma Gmb , Pamela Keck , Biofrontera Inc , European Commission , Drug Administration , Frankfurt Stock Exchange Prime Standard , Frankfurt Stock Exchange , American Academy Of Dermatology , European Medicines Agency , Biofrontera Group , Maruho Co Ltd , Committee For Medicinal Products Human Use , East Asia , American Academy , Biofrontera Pharma Gmbh , Medicinal Products , Human Use , Investor Relations , Prime Standard , Looking Statements , Private Securities Litigation Reform Act , Registration Statement , Public Health ,

BSR Korea's Support Program Acquires $16M in the Global Public Procurement Market

Press release content from PR Newswire. The AP news staff was not involved in its creation.
BSR Korea’s Support Program Acquires $16M in the Global Public Procurement Market
April 12, 2021 GMT
BSR Korea
SEOUL, South Korea, April 12, 2021 /PRNewswire/ BSR Korea (CEO: Baek Seung-Rak) is a government-entrusted agency that runs two national projects this year: Fostering Major Regional Industries in Daejeon held by the Ministry of SMEs and Startups (MSS) and Marketing Support for Companies Specialized in Bio-functional Material in Global Market held by the Public Procurement Service. They are working on a listing of domestic SMEs and marketing activities for overseas public procurement, in relation to sanitization supplies for international organizations, the US federal government, and other EU and ASEAN overseas procurement markets. ....

Soult Ukpyolsi , South Korea , Taejon Gwangyoksi , United States , Baek Seung Rak , Davidh Hwang , Procurement Service , Public Procurement Service , American Hospital Association , Employment Opportunity Commission , Major Regional Industries In Daejeon , Fostering Major Regional Industries , Marketing Support , Companies Specialized , Bio Functional Material , Global Market , Public Procurement , Federal Procurement Service , Equal Employment Opportunity Commission , Southeast Asian , Government Business And Finance , Corporate News , North America , Pr Newswire , Government Contracts , Tenders And Public Work Procurement ,

BeiGene Presents Clinical Data on Sitravatinib in Combination with Tislelizumab at the AACR Annual Meeting 2021

Press release content from Business Wire. The AP news staff was not involved in its creation.
BeiGene Presents Clinical Data on Sitravatinib in Combination with Tislelizumab at the AACR Annual Meeting 2021
April 11, 2021 GMT
CAMBRIDGE, Mass. & BEIJING (BUSINESS WIRE) Apr 11, 2021
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that clinical data on its anti-PD-1 antibody tislelizumab, in combination with the investigational spectrum-selective kinase inhibitor sitravatinib being jointly developed with Mirati Therapeutics, Inc. (Mirati), were presented in two oral presentations at the American Association for Cancer Research (AACR) Annual Meeting 2021. Data presented at the meeting were from two cohorts of a Phase 1b trial (NCT03666143), in patients with unresectable or metastatic melanoma who were refractory or resistant to PD-1/L1 inhibitor ....

United States , New Zealand , United Kingdom , Chuanliang Cui , Bristol Myers Squibb , Jeffrey Goh , Yong Ben , Beigene Ltd , Oncologist At Icon Cancer Centre , Mirati Therapeutics Inc , Exchange Commission , Tislelizumab Clinical Program , China National Medical Products Administration , American Association For Cancer Research , Amgen Inc , Mirati Therapeutics , American Association , Cancer Research , Annual Meeting , Chief Medical Officer , Metastatic Melanoma Refractory , Beijing Cancer Hospital , Medical Oncologist , Icon Cancer Centre , Biologics License Applications , Drug Evaluation ,

AB Science announces the signing of an exclusive licensing agreement with the University of ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
AB Science announces the signing of an exclusive licensing agreement with the University of .
AB ScienceApril 6, 2021 GMT
PRESS RELEASE
AB SCIENCE ANNOUNCES COLLABORATION WITH THE UNIVERSITY OF CHICAGO TO CONDUCT RESEARCH FOR THE PREVENTION AND TREATMENT OF COVID-19 WITH MASITINIB AND OTHER AB SCIENCE PROPRIETARY DRUGS
Paris, April 6 2021, 8am CET
AB Science SA (Euronext - FR0010557264 - AB), together with the Univ ....

United States , University Of Chicago , France General , Arthur Rouill , Jeffrey Freedman , Alain Moussy , Savas Tay , Olivier Hermine , Polsky Center , University Of Chicago Polsky Center , Pritzker School For Molecular Engineering , Scientific Committee , Nir Drayman , Pritzker School , Molecular Engineering , Des Sciences , Azizis A , Euronext Paris , Des March , Public Health , Products And Services , Coronavirus Pandemic , Product Testing , Diagnosis And Treatment , Globe Newswire , Licensing Agreements ,